Ecuador Grants First Compulsory Licence, For HIV/AIDS Drug 22/04/2010 by Catherine Saez, Intellectual Property Watch 7 Comments Ecuador this month granted its first compulsory licence for a patented pharmaceutical since declaring last year that it would utilise international rules allowing it to do so. The move has already brought the country substantial savings due to new competition, according to the Ecuadorean intellectual property office. Other Latin American countries might be drawn to the prospect of reduced drug prices, according to advocates. The rights owner said it is disappointed with the decision.
Free Software Used To Fight Piracy, Broaden Knowledge Access In Ecuador 22/04/2010 by Catherine Saez, Intellectual Property Watch 2 Comments A joint project being launched by a regional non-profit group along with the Ecuador’s intellectual property office (IEPI) aims to reduce software piracy by offering a free software alternative through public libraries. The initiative is meant to encourage the use of legal software and thereby lower the piracy rate.
Panel Dissects Future Challenges Of WHO Budget, Administration 21/04/2010 by Kaitlin Mara for Intellectual Property Watch Leave a Comment The World Health Organization needs to streamline its functions and make more space for civil society, and international health systems must be strengthened in order to achieving public health goals, said panellists at this week’s Geneva Health Forum.
Biodiversity: Bountiful Source For Cosmetics, But Needs Respect, Group Says 21/04/2010 by Catherine Saez, Intellectual Property Watch 3 Comments PARIS- The cosmetics industry is about beauty, but it is also increasingly about biodiversity as consumers show a growing awareness of environmental issues and the loss of biodiversity. As a wishful wink to the 10th meeting of the UN Convention on Biological Diversity (CBD) in Nagoya in October 2010, the Union for Ethical Biotrade (UEBT) held a conference at the Palais de Tokyo in Paris on 15 April.
Geneva Health Forum Addresses Biotech, Trade, Pandemic Flu 21/04/2010 by Catherine Saez and William New, Intellectual Property Watch Leave a Comment Biotechnology, international trade, and pandemic influenza were among the topics discussed at the outset of this year’s Geneva Health Forum.
Geneva Events Address Public Health Solutions For Developing Countries 20/04/2010 by Kaitlin Mara for Intellectual Property Watch Leave a Comment Public health authorities and observers in Geneva this week are discussing problems and possible solutions to medicines pricing and availability in developing countries. But concerns were raised yesterday about a World Health Organization expert group on medicines access and innovation.
Open Source Company Alleges IBM Antitrust; IBM Requests Analysis 20/04/2010 by Catherine Saez, Intellectual Property Watch 4 Comments Computer giant IBM is facing an antitrust claim before the European Commission brought by an open source software company alleging that IBM is preventing customers from using that software. Meanwhile, the open source community is worried that the use of intellectual property rights by IBM – a leading open source software maker – to block a competitor will endanger free and open source software and might uncap other IP rights claims from other players. IBM, for its part, is reaffirming its support to open source community and has asked the competing company to explain how its software does not infringe on IBM IP rights.
UNITAID Patent Pool Budget Approved; Implementation To Begin 13/04/2010 by Kaitlin Mara for Intellectual Property Watch 4 Comments Today, board members of international drug purchasing mechanism UNITAID approved a 2010 budget for a pioneering patent pool initiative.
Smooth Criminal Harmonisation — ACTA, EU And IPR Enforcement 08/04/2010 by Intellectual Property Watch 2 Comments Lassi Jyrkkiö writes: Anything one can consider as politically cool from an EU perspective, ACTA (Anti-Counterfeiting Trade Agreement, the multilateral treaty to combat counterfeiting and piracy) negotiations have got it all: the internet, the USA, large potential for media exposure and a hitherto Nixonian element of secrecy balanced by a flow of thrilling documents leaked by generous deep-throats.
Risk Of Wrongful Medicines Seizures Seen In EU-Central America Trade Deal 06/04/2010 by David Cronin for Intellectual Property Watch 1 Comment A new accord designed to bolster political and economic ties between the European Union and Central America could result in greater seizures of medicines whenever pharmaceutical companies allege that their patents have been infringed, public health advocates have warned.